Related Experiment Videos
Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis
1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, PRC. alice_ykchan@yahoo.com.hk
We describe a Chinese woman who developed severe heart failure 3 years from the onset of systemic lupus erythematosus (SLE). Endomyocardial biopsy confirmed lupus myocarditis, with focal infiltrates of small lymphocytes and some polymorphic neutrophils. The conventional treatment for cardiac failure plus oral prednisolone failed to bring clinical and echocardiographical improvement until the addition of intravenous (i.v.) 'pulse' cyclophosphamide. Three weeks after i.v. cyclophosphamide treatment, there was significant improvement of her heart failure symptoms with improvement in the ejection fraction from 19% to 63%.
We describe a Chinese woman who developed severe heart failure 3 years from the onset of systemic lupus erythematosus (SLE). Endomyocardial biopsy confirmed lupus myocarditis, with focal infiltrates of small lymphocytes and some polymorphic neutrophils. The conventional treatment for cardiac failure plus oral prednisolone failed to bring clinical and echocardiographical improvement until the addition of intravenous (i.v.) 'pulse' cyclophosphamide. Three weeks after i.v. cyclophosphamide treatment, there was significant improvement of her heart failure symptoms with improvement in the ejection fraction from 19% to 63%.
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Myocarditis IV: Nursing Management
Pericarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pericarditis IV: Nursing Management